周围B细胞水平预测了PD-1免疫治疗中晚期黑色素瘤患者的疗效和整体存活率

Xiaoli Liu1, Shuochuan Liu2, Zhiqiang Jiang3

  • 1Department of Integrated Traditional Chinese & Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China.

Immunotherapy
|December 21, 2023
PubMed
概括

较低的外围B细胞计数与接受计划死亡-1 (PD-1) 阻断免疫治疗的晚期恶性黑色素瘤患者的更好的结果相关. 这一发现表明B细胞可以预测治疗反应和预后.